WHO ICTRP trial
An Clinical Study of Evecare Forte Liquid in PCOS (Polycystic Ovarian Syndrome)
CTRI/2017/12/011004 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2017/12/011004 |
|---|---|
| Public title | An Clinical Study of Evecare Forte Liquid in PCOS (Polycystic Ovarian Syndrome) |
| Scientific title | An Open Label Clinical Study to Evaluate the Efficacy and Safety of Evecare Forte Liquid in PCOS (Polycystic Ovarian Syndrome)â?? |
| Primary sponsor | The Himalaya Drug Company |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: E282- Polycystic ovarian syndrome |
| Interventions | Intervention1: Evecare Forte Liquid: 20 ml twice daily for 3 months Control Intervention1: Nil: Nil |
| Registration date | Dec 28, 2017 |
| Target size | 20 |
| Secondary IDs | HDC/CP/PP/49/2017 14-April 2017 V1 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: